Monster Beverage Corp (MNST)
As-reported financials and SEC filings for Monster Beverage Corp. The latest annual period is FY2025. The latest reported quarter is Q2 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.
Snapshot
Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.
What changed at Monster Beverage
- Revenue grew 10.7% to $8.3B in FY2025, faster than the 4.9% the year before.
- Operating margin is 29.2% in FY2025, -3.3 pp against 32.4% in FY2021.
- Most recent quarter Q2 FY2026: revenue $2.5B, up 20.2% from Q2 FY2025.
- Free cash flow was $2.0B in FY2025, 23.7% of revenue.
- Net income rose 26.3% to $1.9B in FY2025.
Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.
Peer comparison
Where Monster Beverage’s fundamentals sit among the 131 Consumer Staples companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).
Monster Beverage’s operating margin of 29.2% ranks in the 97th percentile of the 117 Consumer Staples companies reporting it. Monster Beverage’s FCF margin of 23.7% ranks in the 97th percentile of the 114 Consumer Staples companies reporting it. Monster Beverage’s net margin of 23.0% ranks in the 94th percentile of the 121 Consumer Staples companies reporting it.
No reported insider transactions (codes P/S) in the last 90 days. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →
Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.
Institutional ownership
Held by 3 of the superinvestors we track (plus 7 quant / multi-strat books), based on each investor’s most recent 13F; periods vary by investor (newest: Q2 2026).
| Investor | As of | Position value | Shares | Change |
|---|---|---|---|---|
| AQR Capital Managementquant | Q2 2026 | $260.2M | 2.7M | Reduced |
| Maverick Capital | Q2 2026 | $252.8M | 2.6M | Added |
| Citadel Advisorsquant | Q2 2026 | $211.8M | 2.2M | Added |
| D. E. Shawquant | Q2 2026 | $139.7M | 1.5M | Added |
| Two Sigma Investmentsquant | Q2 2026 | $77.8M | 809.9K | Reduced |
| Bridgewater Associates | Q2 2026 | $58.2M | 605.4K | Reduced |
| Gotham Asset Management | Q2 2026 | $51.3M | 534.1K | Reduced |
| Millennium Managementquant | Q2 2026 | $36.4M | 378.5K | Added |
| Renaissance Technologiesquant | Q2 2026 | $30.5M | 316.8K | Reduced |
| Point72 Asset Managementquant | Q2 2026 | $10.5M | 109.6K | New |
From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.
Recent insider activity
Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.
| Trade date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
2026-06-10 filed 2026-06-12 | Guy CarlingCEO, EMEA and OSP | Sell | 19.0K | $90.90 | $1.7M |
2026-05-14 filed 2026-05-15 | Mark J. HallDirector | Sell | 54.0K | $85.81 | $4.6M |
2026-05-14 filed 2026-05-15 | Emelie TirreChief Strategy Officer | Sell | 10.0K | $85.74 | $857K |
2026-05-13 filed 2026-05-15 | Emelie TirreChief Strategy Officer | Sell | 88.7K | $85.96 | $7.6M |
2026-05-13 filed 2026-05-15 | Thomas J. KellyChief Financial Officer | Sell | 7.0K | $87.81 | $615K |
Reported non-derivative purchases and sales (codes P/S), which may be open-market or private. Excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.
Short interest
Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 2026-09-30 | 45.4M | +7.3% | 4.25 |
| 2026-09-15 | 42.3M | -3.5% | 4.52 |
| 2026-08-31 | 43.9M | +14.1% | 4.48 |
| 2026-08-14 | 38.4M | +109.4% | 3.40 |
| 2026-07-31 | 18.4M | -1.6% | 3.20 |
| 2026-07-15 | 18.7M | -7.2% | 3.59 |
| 2026-06-30 | 20.1M | -9.9% | 3.04 |
| 2026-06-15 | 22.3M | +6.3% | 3.99 |
Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.
Income statement (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | $8.29B | $7.49B | $7.14B | $6.31B | $5.54B |
| Gross profit | |||||
| Operating income | $2.42B | $1.93B | $1.95B | $1.58B | $1.80B |
| Pre-tax income | $2.48B | $1.99B | $2.07B | $1.57B | $1.80B |
| Net income | $1.91B | $1.51B | $1.63B | $1.19B | $1.38B |
| Diluted EPS | — | — | — | — | — |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures (free cash flow is operating cash flow minus capital expenditures, which can differ from a company’s own definition); “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Diluted EPS includes discontinued operations where a company reports them. Cash & Equivalents excludes short-term investments and may include restricted cash where that is the figure the company tags. Full details: where the numbers come from.
Balance sheet (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Cash and equivalents | $2.09B | $1.53B | $2.30B | $1.31B | $1.33B |
| Current assets | $5.36B | $3.64B | $5.59B | $4.76B | $4.68B |
| Total assets | $9.99B | $7.72B | $9.69B | $8.29B | $7.80B |
| Current liabilities | $1.45B | $1.10B | $1.16B | $1.00B | $965.1M |
| Long-term debt | — | $374.0M | $0 | — | — |
| Total liabilities | |||||
| Total equity | $8.25B | $5.96B | $8.23B | $7.03B | $6.57B |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures (free cash flow is operating cash flow minus capital expenditures, which can differ from a company’s own definition); “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Diluted EPS includes discontinued operations where a company reports them. Cash & Equivalents excludes short-term investments and may include restricted cash where that is the figure the company tags. Full details: where the numbers come from.
Cash flow (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Operating cash flow | $2.10B | $1.93B | $1.72B | $887.7M | $1.16B |
| Capital expenditure | $132.3M | $264.1M | $221.4M | $188.7M | $43.9M |
| Free cash flow |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures (free cash flow is operating cash flow minus capital expenditures, which can differ from a company’s own definition); “adj” means restated for a stock split (tap or hover a figure to see how it was calculated or what was filed). Diluted EPS includes discontinued operations where a company reports them. Cash & Equivalents excludes short-term investments and may include restricted cash where that is the figure the company tags. Full details: where the numbers come from.
Quarterly trend
| Quarter | Revenue | Revenue YoY | Net income | Diluted EPS |
|---|---|---|---|---|
| Q2 FY2026 | $2.54B | 20.2% | $584.5M | — |
| Q1 FY2026 | $2.35B | 26.9% | $569.5M | — |
| Q4 FY2025 | 17.6% | |||
| Q3 FY2025 | $2.20B | 16.8% | $524.5M | — |
| Q2 FY2025 | $2.11B | 11.1% | $488.8M | — |
| Q1 FY2025 | $1.85B | -2.3% | $443.0M | — |
| Q4 FY2024 | 4.7% | |||
| Q3 FY2024 | $1.88B | — | $370.9M | — |
Latest 8 quarters, from company XBRL filings on SEC EDGAR. A dotted underline marks a fourth-quarter figure we calculated from the full year and the first nine months. Revenue YoY is our calculation too: each quarter against the same quarter a year earlier.
Company facts
Selected SEC filings
Largest Consumer Staples peers
MNST head to head
Monitor MNST
Get an alert when Monster Beverage files something material, see which superinvestors own it, and ask its filings a question with cited answers.
Monitor MNST freeIncludes one free filing-grounded research answer. Or check your whole portfolio, no account needed.
Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.